Information Library

For Emerging Biopharma

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Emerging Biopharma Service Fact Sheet

    May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • BIOS Standardize Data with SPARC

    February 2, 2010
    There is an increasing global requirement for Clinical Data Interchange Standards Consortium (CDISC) -based standardized data for regulatory submissions. At Quintiles, we have proactively addressed this need by training our staff, gaining experience, and developing and implementing innovative solutions for creating data that adhere to current CDISC Study Data Tabulation Model (SDTM) specifications.

  • Enabling Transformation

    September 30, 2009
    Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company.

  • Should Venture Firms Bundle Their Biotech Portfolios?

    June 29, 2009
    Ron Wooten, president of NovaQuest, an investment and business-development unit of Quintiles Transnational Corp., a contract-research organization, thinks so.

  • Novaquest and Elli Lilly

    August 1, 2008
    A Pharma TV interview with Ben Cons

  • Partnering Positions

    August 1, 2008
    A Pharma TV interview with Ben Cons

  • Leveraging a $2 Billion Portfolio

    August 1, 2008
    A Pharma TV interview with Ben Cons

  • Reducing Risk

    August 1, 2008
    A Pharma TV interview with Ben Cons

  • The Next Generation of Partnerships

    August 1, 2008
    A Pharma TV interview with Ben Cons

Page 1 of 1 (10 results)

Subscribe to Email Based on Your Interests

Set preferences